MICB and plasma cell myeloma: Our results (Figure 7A), together with the gene-expression data from MM samples collected by the Multiple Myeloma Research Foundation (MMRF) in the Genomic Data Commons (GDC) data portal [22], indicate that most myeloma cells show high expression of HLA-ABC, MICA, and MICB, which are suitable for T cell and CIK cell immunotherapy (Figure 7A and Supplemental Figure 10A).